In the current study, PPARGC1A and PPARGC1B transcript levels were reduced, which was previously found in the human SM of not only T2D patients but also of offspring from insulin-resistant individuals [58]. This evidence concerns the gene PPARGC1B and type 2 diabetes mellitus.